Printer Friendly

FORMER COMPUCHEM CHAIRMAN, CURRENT OFFICERS AND MANAGERS ACQUIRE COMPANY'S ENVIRONMENTAL SERVICES DIVISION

 RESEARCH TRIANGLE PARK, N.C., Sept. 15 /PRNewswire/ -- The president of CompuChem, a subsidiary of Roche Biomedical Laboratories, Inc., and a group of senior managers of its environmental division, assisted by a team of outside investors led by former CompuChem chairman, Harvey (Chet) Krentzman of Chestnut Hill, Mass. announced today they have completed the purchase of the environmental laboratories services division of the company. Terms of the sale were not disclosed.
 According to CompuChem president, Gerard (Kees) Verkerk, the new company has been named CompuChem Environmental Corporation and will remain in its present quarters and retain all 176 of its current employees, many of whom have been with the company since its founding in 1979. Krentzman, CompuChem's chairman at the time of its sale to Roche, will return as chairman of the board and Verkerk will serve as president and chief executive officer.
 In February of 1992 Roche acquired CompuChem and decided to divest the environmental division so it could focus its resources on the drug testing services. The Forensic Drug Testing Division will continue to be owned and operated as a subsidiary of Roche Biomedical Laboratories.
 "The scientists and managers of CompuChem Environmental pioneered the environmental testing industry," said Verkerk. "We see significant growth ahead for CompuChem Environmental as it continues to supply high quality and customer-oriented analytical services to the clean-up segment of the $1.2 billion analytical services industry. We will continue to utilize state-of-the-art instrumentation and methods that respond well to the complex needs of government and industrial hazardous waste remediation projects."
 CompuChem Environmental provides computer-aided high volume, close tolerance analytical services for the detection of hazardous materials in the environment. It is a leading supplier to the U.S. Environmental Protection Agency and to environmental engineering and consulting firms. Verkerk said future growth will come from providing testing services to The U.S. Department of Energy and Department of Defense. In addition, the company is building relationships with large chemical, oil and other processing and manufacturing operations.
 -0- 9/15/93
 /CONTACT: Ronald B. Scott of Ruder Finn, Boston, 617-242-0009, for CompuChem/


CO: CompuChem; Roche Biomedical Laboratories ST: North Carolina, Massachusetts IN: CPR ENV SU: TNM

JL-CM -- NE006 -- 2259 09/15/93 12:56 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 15, 1993
Words:370
Previous Article:SEARS CATALOG OUTLET STORES REACH THE END OF AN ERA; SEPTEMBER 19 TARGETED AS CLOSING DAY FOR ALL 67 STORES
Next Article:THE BOSTON FIVE REPORTS MORTGAGE PRODUCTION TOTALS
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters